8TV8 image
Deposition Date 2023-08-17
Release Date 2024-01-17
Last Version Date 2024-11-13
Entry Detail
PDB ID:
8TV8
Title:
Crystal structure of nontypeable Haemophilus influenzae SapA
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.25 Å
R-Value Free:
0.22
R-Value Work:
0.19
Space Group:
P 41 21 2
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:ABC-type transport system, periplasmic component, involved in antimicrobial peptide resistance
Gene (Uniprot):sapA
Chain IDs:A
Chain Length:564
Number of Molecules:1
Biological Source:Haemophilus influenzae 86-028NP
Primary Citation
Antimicrobial Peptide Recognition Motif of the Substrate Binding Protein SapA from Nontypeable Haemophilus influenzae .
Biochemistry 63 294 311 (2024)
PMID: 38189237 DOI: 10.1021/acs.biochem.3c00562

Abstact

Nontypeable Haemophilus influenzae (NTHi) is an opportunistic pathogen associated with respiratory diseases, including otitis media and exacerbations of chronic obstructive pulmonary disease. NTHi exhibits resistance to killing by host antimicrobial peptides (AMPs) mediated by SapA, the substrate binding protein of the sensitivity to antimicrobial peptides (Sap) transporter. However, the specific mechanisms by which SapA selectively binds various AMPs such as defensins and cathelicidin are unknown. In this study, we report mutational analyses of both defensin AMPs and the SapA binding pocket to define the specificity of AMP recognition. Bactericidal assays revealed that NTHi lacking SapA are more susceptible to human beta defensins and LL-37, while remaining highly resistant to a human alpha defensin. In contrast to homologues, our research underscores the distinct specificity of NTHi SapA, which selectively recognizes and binds to peptides containing the charged-hydrophobic motif PKE and RRY. These findings provide valuable insight into the divergence of SapA among bacterial species and NTHi SapA's ability to selectively interact with specific AMPs to mediate resistance.

Legend

Protein

Chemical

Disease

Primary Citation of related structures